Ƶ

Record-Breaking Obesity Certifications; 365-Day CGM Data; Med Spa Mounjaro Lawsuits

— News and commentary from the endocrinology world

Ƶ MedicalToday
Endo Break over a computer rendering of a man with illustrated body organs.

A record-breaking number of U.S. physicians applied this year, according to the American Board of Obesity Medicine.

Two Roche distributors are under investigation in Pakistan after 12 following an injection of bevacizumab (Avastin), a cancer drug used off-label for diabetes-related eye conditions. (Reuters)

The American Thyroid Association released a new statement guiding clinicians on . (Thyroid)

The (CGM) proved safe and accurate with 365 days of wear, Senseonics Holdings announced; the company plans to submit the data to the FDA for approval. Currently no CGM system is approved for year-long use.

In a press release, Eli Lilly explained why it sued medical spas, wellness centers, and compounding pharmacies for selling products , which may be approved for weight loss this year.

Women exposed to , like phenols and parabens, had higher odds of melanoma and ovarian cancer. (Journal of Exposure Science & Environmental Epidemiology)

SGLT2 inhibitors and GLP-1 receptor agonists may be with type 2 diabetes when it comes to cardiovascular and kidney outcomes. (Journal of the Royal Society of Medicine)

Even in states where gender-affirming care for minors is legal, some providers out of liability concerns. (AP)

In fact, more than half of surveyed said they were concerned about the risk of legal action against them. (Journal of the Endocrine Society)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.